STRATA Skin Sciences, Inc. — Director's Dealing 2011

Apr 26, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2011-04-25

Reporting Person: Steinhart Richard I (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-25	Stock Option	$3.81	A	100000	Acquired	2021-04-25	Common Stock (100000)	Direct

Footnotes

F1: On April 25, 2011 100,000 options were granted of which 80,000 options shall vest immediately and the remaining 20,000 options shall vest upon PMA approval for MelaFind system from the United States Food and Drug Administration.